Safety evaluation of tirofiban. - Wikidata - wikimedia - TriplyDB

Safety evaluation of tirofiban.

Safety evaluation of tirofiban.

http://www.wikidata.org/entity/Q33391065

about

Triple antiplatelet therapy in acute coronary syndromes.

P2860

Q37929162-036FA4C0-E9F7-42A9-9F5F-E43128E5531A

P2860

Safety evaluation of tirofiban.

http://www.wikidata.org/entity/Q33391065

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Safety evaluation of tirofiban.

@ast

Safety evaluation of tirofiban.

@en

type

label

Safety evaluation of tirofiban.

@ast

Safety evaluation of tirofiban.

@en

prefLabel

Safety evaluation of tirofiban.

@ast

Safety evaluation of tirofiban.

@en

P1433

Q33391065-901AAE00-D5A6-4BCC-A39D-6E592D4936C2

P1476

Q33391065-4EFADF40-37BC-409D-B1CC-DE82AA377CD8

P2860

Q33391065-060D6E98-5358-453A-8C54-87A4431EE4B6

Q33391065-064D3118-FD33-401C-8502-1EF90D21AB35

Q33391065-07EDBA62-6D0E-44F7-96A1-4729BAA1EB46

Q33391065-0A524880-F816-4305-BB6D-EF205DC524C3

Q33391065-238AF76E-95FC-4BB8-BCDB-12660A639BAF

Q33391065-270AC76D-286F-4ABC-A40F-A91E260833F6

Q33391065-2F91A548-A626-43D8-940B-C100C726F044

Q33391065-321A181C-0D2A-47B0-8E29-8A4798232C34

Q33391065-3BA1C22C-D02D-4B87-934B-A1DBC6923568

Q33391065-43EABC00-11B8-4CD2-A5F3-236EAA2B85D9

P304

Q33391065-B22D4BB1-DED4-4120-A9BA-FC78903410A1

P31

Q33391065-9789D09E-3E06-4848-A018-5338B68C5287

P356

Q33391065-1CF23C6A-683B-4F62-AE67-6A534DFCE79A

P407

Q33391065-F8F26C86-A4A2-4E4F-B146-81E0FDA46D70

P433

Q33391065-CB37AE3A-DED1-41BA-8997-26C3FE146CFC

P478

Q33391065-BEB41CB7-CF09-490F-AB10-459CA9AC6B2B

P50

Q33391065-C91D403E-7E5C-41EF-AD3B-354C69F3A99A

Q33391065-F327E04D-9CE6-4A86-AAE5-4E7505BB9A7D

P577

Q33391065-ABC87C8C-1570-49F1-84BD-F72D8BD0CD4F

P698

Q33391065-878D2834-3D39-4033-A0AF-1C36D3C1ED68

P356

14740338.2010.507189

P1433

Expert Opinion on Drug Safety

P1476

Safety evaluation of tirofiban.

@en

P2860

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial

Comparative pharmacology of GP IIb/IIIa antagonists

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

NRMI and current treatment patterns for ST-elevation myocardial infarction

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Platelet function predicts myocardial damage in patients with acute myocardial infarction

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty

Bivalirudin during primary PCI in acute myocardial infarction

P304

801-819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2010.507189

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Marco Valgimigli

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20670206

http://www.w3.org/2001/XMLSchema#string